
View larger version (32K):
[in a new window]
|
Fig. 1. BTG2TIS21/PC3 promoter activation by TA- and N-p73 in wt-p53 neuroblastoma cell lines but not in wt-p53 breast cancer line MCF-7. (A) Schematic representation of pGL3-reporter constructs containing p53 binding site (BS) at 119, as previously described (Duriez et al., 2002 ); long BTG2TIS21/PC3 promoter sequence fragments of 2700 bp (2700) and short promoter fragment (266). (B) SH-SY5Y, (C) IMR-32, (D) LAN-1 and (E) MCF-7 cells were transiently co-transfected with pBTG2-Luc plasmid carrying long (2700) or short (266) promoter sequences in the presence of either TA- or Np73 expressing vectors or empty control plasmids. Transfection techniques and luciferase activity measurements were carried out as described in the Materials and Methods. Error bars represent standard deviation calculated from three independent experiments. Cells were transfected with empty vector, TAp73 , Np73 , p53DD, TAp73 + p53, Np73 + p53 as indicated.
|